Takara Bio Europe Launches Shasta™ Single-Cell System, Advancing High-Throughput Oncology Biomarker Discovery

Takara Bio Europe, a wholly owned subsidiary of Takara Bio Inc., announces the launch of the Shasta™ Single-Cell System at the 2024 Human Cell A...

September 27, 2024 | Friday | News
Dräger Honored with 2024 AARC Zenith Award for Excellence in Respiratory Care Support

Award criteria include quality of equipment, service and customer support The American Association for Respiratory Care (AARC) selected Dräger for ...

September 25, 2024 | Wednesday | News
Oxford-Harrington Rare Disease Centre Kicks Off Bi-Annual Symposium at University of Oxford

The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the University of Oxford, UK and Harrington Discovery Institute at U...

September 24, 2024 | Tuesday | News
ESMO 2024 Congress: Breakthroughs in Cancer Treatment and Key Approvals

The European Society for Medical Oncology (ESMO) 2024 Congress, held from September 13 to 17 in Barcelona, brought together global oncology experts to un...

September 23, 2024 | Monday | News
Immutep Presents Promising Phase IIb Trial Results of Efti and KEYTRUDA® at ESMO 2024

Results delivered in prestigious Proffered Paper oral presentation at ESMO Congress 2024 In patients with any PD-L1 expression (CPS ≥1), efti in co...

September 17, 2024 | Tuesday | News
Rapid Micro Biosystems to Present at Morgan Stanley’s 22nd Annual Global Healthcare Conference

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), a pioneering life sciences technology firm that offers critical automation solut...

September 04, 2024 | Wednesday | News
Thermo Fisher Scientific to Showcase Comprehensive Diagnostics Portfolio at ADLM 2024

Thermo Fisher Scientific Inc. will showcase its broad diagnostics portfolio and host a series of customer-led workshops and presentations that highlight ...

July 26, 2024 | Friday | News
Johnson & Johnson Announces Positive Results from Phase 3 Vivacity-MG Study of Nipocalimab in Patients with Generalized Myasthenia Gravis

Johnson & Johnson  announced positive results from the nipocalimab Phase 3 Vivacity-MG study in patients with generalized myasthenia gravis (gMG...

July 01, 2024 | Monday | Reports
Thermo Fisher Scientific's PPD Clinical Research Business Earns 13th Consecutive CRO Leadership Award

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, is embracing the theme of the 60th annual Drug ...

June 17, 2024 | Monday | News
AstraZeneca's CALQUENCE® Shows Significant Improvement in Progression-Free Survival for Untreated Mantle Cell Lymphoma

Positive results from the ECHO Phase III trial showed AstraZeneca’s CALQUENCE®(acalabrutinib) in combination with bendamustine and rituximab de...

June 17, 2024 | Monday | News
UCB Presents Promising Data on Certolizumab Pegol for Pregnant Women and High RF RA Patients at EULAR 2024

  Pharmacokinetic data from the CHERISH study suggest that pregnant women treated with certolizumab pegol can maintain their do...

June 17, 2024 | Monday | News
Abu Dhabi Signs Landmark MoU with ADIO, Etihad Airways, and AD Ports Group to Become Global Pharma and Life Sciences Hub

BIO International Convention 2024, The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, and Abu Dhabi...

June 10, 2024 | Monday | News
Ecolab and Repligen Unveil Groundbreaking Protein A Chromatography Resin at BIO 2024

Ecolab announced that its Purolite resin business, together with Repligen Corporation, a life sciences company focused on bioprocessing technology leader...

June 04, 2024 | Tuesday | News
BIO 2024: U.S. Officials Emphasize Vital National Security Partnership with Biotech Industry

At the opening of the 2024 BIO International Convention in San Diego, federal officials underscored the critical role of the biotechnology industry in sa...

June 04, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close